Bacterial infections in infants 60 days and younger: Epidemiology, resistance, and implications for treatment

Archives of Pediatrics and Adolescent Medicine

Volumn 153, Issue 6, 1999, Pages 611-614

  Sadow, Karin Berger ^a,b   Derr, Robert ^c   Teach, Stephen J ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTAZIDIME; GENTAMICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATION; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CONTROLLED STUDY; EMERGENCY WARD; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; INFANT DISEASE; LISTERIA MONOCYTOGENES; MAJOR CLINICAL STUDY; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS PNEUMONIAE; URINE CULTURE;

EID: 0033044802     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.153.6.611     Document Type: Article

References (20)

1. Gladstone IM, Ehrenkranz RA, Edberg SC, et al. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J. 1990;9:819-825.
2. Freidland IR, McCracken GH. Neonatal sepsis and meningitis. In: Rudolph AM, Hoffman JI, Rudolph ED, eds. Rudolph's Pediatrics. Stanford, Conn: Appleton & Lange; 1996:536-544.
3. Fleisher GR. Infectious disease emergencies. In: Fleisher GR, Ludwig S, eds. Textbook of Pediatric Emergency Medicine. Baltimore, Md: Williams & Wilkins; 1993: 596-606.
4. Gordon RC, Barrett FF, Clark DJ. Influence of several antibiotics, singly and in combination, on the growth of Listeria monocytogenes. J Pediatr, 1972:80:667-670.
5. American Academy of Pediatrics, Peter G, ed. 1997 Red Book: Report of the Committee on Infectious Diseases. 24th ed. Elk Grove Village, III: American Academy of Pediatrics; 1997:203.
6. Sanford JP, Gilbert DN, Moellering RC, Sande MA. The Sanford Guide to Antimicrobial Therapy. 27th ed. Vienna, Va: Antimicrobial Therapy Inc; 1997:4.
7. Tappero JW, Schuchat A, Deaver KA, et al. Reduction in the incidence of human listeriosis in the United States. JAMA. 1995;273:1118-1122.
8. Joseph TA, Pyati SP, Jacobs N. Neonatal early onset Escherichia coli disease. Arch Pediatr Adolesc Med. 1998;152:35-40.
9. Antimicrobial Susceptibility Data. Washington, DC: Children's National Medical Center; January-December 1997.
10. Moellering RC. Principles of anti-infective therapy. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and Practice of Infectious Diseases. 3rd ed. New York, NY: Churchill Livingstone; 1990:214-216.
11. Albritton WL, Wiggins GL, Feeley JC. Listeriosis. In: Feigen RD, Cherry JD, eds. Textbook of Pediatric Infectious Diseases. Philadelphia, Pa: WB Saunders Co; 1981:911-916.
12. Albritton WL, Wiggins GL, Feeley, JC. Neonatal listeriosis: distribution of serotypes in relation to age at onset of disease. J Pediatr. 1976;88:481-483.
13. Schaad UB, McCracken GH Jr, Loock CA, et al. Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. J Infect Dis. 1981;143:156-163.
14. Fernandez M, Hickman ME, Baker CJ. Antimicrobial susceptibilities of group B streptococci isolated between 1992 and 1996 from patients with bacteremia or meningitis. Antimicrob Agents Chemother. 1998;42:1517-1519.
15. Kim K. Effect of antimicrobial therapy for experimental infections due to group B streptococcus on mortality and clearance of bacteria. J Infect Dis. 1987;155: 1233-1241.
16. Hall MA, Ducker DA, Lowes JA, et al. A randomized prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis. Drugs. 1988;35(suppl 2):169-177.
17. Bradley JS, Ching DL, Wilson TA, et al. Once daily ceftriaxone to complete therapy of uncomplicated group B streptococcal infection in neonates: a preliminary report. Clin Pediatr. 1992;31:274-278.
18. Moellering RC. Emergence of enterococcus as a significant pathogen. Clin Infect Dis. 1992;14:1173-1178.
19. Dobson SR, Baker CJ. Enterococcal sepsis in neonates: features by age at onset and occurrence of focal infection. Pediatrics. 1990;85:165-171.
20. Jernigan DB, Centron MS, Breiman RF. Minimizing the impact of drug-resistant Streptococcus pneumonias: a strategy from the DRSP working group. JAMA. 1996;275:206-209.